Harnessing the Enemy Within: Adapting Century-Old Phage Therapeutics Technology to Tackle AMR
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
$2995
Bacteriophages, first discovered in 1915 but later eclipsed by antibiotics, are now undergoing a renaissance into a much-needed therapeutic class with high specificity and a long-established safety record, in the battle against life-threatening bacterial infections with antimicrobial resistance (AMR).
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
See what our customers are saying
Related reports
View more Product Type reports
New
New
New